CMS Transparency Rule Spotlights Hospital Markups Of Drug Prices

By John Wilkerson / February 18, 2021 at 5:34 PM
The CMS hospital price transparency requirement that took effect Jan. 1 could result in more patients receiving physician-administered drugs in health care settings with lower drug prices than hospitals, according to a report by Wall Street firm Sanford C. Bernstein. Starting Jan. 1, hospitals were required to post online real-world prices for items and services they provide, including drugs. Previously, CMS required that hospitals post their so-called chargemaster rates online, but chargemaster rates aren’t useful to consumers, so CMS updated...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.